News & Publications


Learn more about Prous Institute and our progress in drug discovery, technology, industry partnerships, collaborations and scientific articles.

Case Study 1 Now Available: New Approaches to the Discovery of Targeted Therapies I: Discovery of SGLT2 Inhibitors to Control Hyperglycemia in Type 2 Diabetes

Illustrates how new targeted therapies for type 2 diabetes can be discovered using the Prous Institute SYMMETRY® drug discovery platform. The approach has been successfully applied across other diverse therapeutic targets and disease areas, including cancer, pain and neurodegeneration. The platform aims to speed up the process of drug discovery and development, reducing time cost and attrition rates.


To receive your PDF copy of Case Study 1, please contact us.